Breakthrough immunotherapy for rare cancer registered in South Africa

IOL | 05.08.2026 17:54
A groundbreaking immunotherapy has been registered in South Africa for recurrent or metastatic nasopharyngeal carcinoma, a rare and aggressive cancer.